DNA甲基化谱作为神经肿瘤学发现与精准诊断的模型
本文综述DNA甲基化谱在中枢神经系统肿瘤分类中的应用,指出甲基化阵列提高了诊断精确性和可靠性,并为发现新肿瘤类型提供框架,同时介绍其与突变/融合的密切关系及免费机器学习分类器的辅助作用。
要点
- DNA甲基化阵列提高了中枢神经系统肿瘤诊断的精确性和可靠性。
- 甲基化数据与关键突变/融合常存在密切关系,有助于发现新肿瘤类型。
- 免费机器学习分类器促进了甲基化数据在神经肿瘤分类学中的应用。
核心结论
- DNA甲基化谱在中枢神经系统肿瘤分类中具有实用价值,尤其有助于新发现的和罕见的肿瘤类型,并有助于细化现有类型。
研究设计与样本
- 本文为综述,检索范围未在原文中明确报告。
主要发现
- 2016年世界卫生组织(WHO)分类更新将分子诊断标准引入特定实体的定义。
- DNA甲基化阵列的出现提高了诊断精确性和可靠性,并为发现新肿瘤类型提供了有效框架。
- 许多情况下,突变/融合与DNA甲基化特征之间存在密切关系。
- 与临床诊断兼容的技术以及免费可及的基于机器学习的分类器,大大促进了甲基化数据在神经肿瘤分类学中的应用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent years have witnessed a shift to more objective and biologically-driven methods for central nervous system (CNS) tumor classification. The 2016 world health organization (WHO) classification update ("blue book") introduced molecular diagnostic criteria into the definitions of specific entities as a response to the plethora of evidence that key molecular alterations define distinct tumor types and are clinically meaningful. While in the past such diagnostic alterations included specific mutations, copy number changes, or gene fusions, the emergence of DNA methylation arrays in recent years has similarly resulted in improved diagnostic precision, increased reliability, and has provided an effective framework for the discovery of new tumor types. In many instances, there is an intimate relationship between these mutations/fusions and DNA methylation signatures. The adoption of methylation data into neuro-oncology nosology has been greatly aided by the availability of technology compatible with clinical diagnostics, along with the development of a freely accessible machine learning-based classifier. In this review, we highlight the utility of DNA methylation profiling in CNS tumor classification with a focus on recently described novel and rare tumor types, as well as its contribution to refining existing types.
引用
- Pratt D, Sahm F, Aldape K, et al. DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology. Neuro Oncol. 2021. PMID: 34725697. doi:10.1093/neuonc/noab143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。